Cannabinoids Decrease the Th17 Infla... [J Neuroimmune Pharmacol. 2013] - PubMed - NCBI

Marijuana's cannabinoids improve human health by reducing systemic inflammation which is a root cause for many degenerative diseases. J Neuroimmune Pharmacol. 2013 Jul 28. [Epub ahead of print]

Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype.

Kozela E, Juknat A, Kaushansky N, Rimmerman N, Ben-Nun A, Vogel Z.


The Dr Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel,


Cannabinoids, the Cannabis constituents, are known to possess anti-inflammatory properties but the mechanisms involved are not understood. Here we show that the main psychoactive cannabinoid, Δ-9-tetrahydrocannabinol (THC), and the main nonpsychoactive cannabinoid, cannabidiol (CBD), markedly reduce the Th17 phenotype which is known to be increased in inflammatory autoimmune pathologies such as Multiple Sclerosis. We found that reactivation by MOG35-55 of MOG35-55-specific encephalitogenic T cells (cells that induce Experimental Autoimmune Encephalitis when injected to mice) in the presence of spleen derived antigen presenting cells led to a large increase in IL-17 production and secretion. In addition, we found that the cannabinoids CBD and THC dose-dependently (at 0.1-5 μM) suppressed the production and secretion of this cytokine. Moreover, the mRNA and protein of IL-6, a key factor in Th17 induction, were also decreased. Pretreatment with CBD also resulted in increased levels of the anti-inflammatory cytokine IL-10. Interestingly, CBD and THC did not affect the levels of TNFα and IFNγ. The downregulation of IL-17 secretion by these cannabinoids does not seem to involve the CB1, CB2, PPARγ, 5-HT1A or TRPV1 receptors. In conclusion, the results show a unique cannabinoid modulation of the autoimmune cytokine milieu combining suppression of the pathogenic IL-17 and IL-6 cytokines along with boosting the expression of the anti-inflammatory cytokine IL-10.

via Cannabinoids Decrease the Th17 Infla... [J Neuroimmune Pharmacol. 2013] - PubMed - NCBI.

Obesity and cannabis use: results from 2 repr... [Am J Epidemiol. 2011] - PubMed - NCBI

Smoking marijuana significantly protects users from obesity and related diseases. Tell someone today! Am J Epidemiol. 2011 Oct 15;1748:929-33.  2011 Aug 24.

Obesity and cannabis use: results from 2 representative national surveys.                                                                                              Le Strat Y, Le Foll B.SourceTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.                                                                                   Abstract: The role of cannabis and endocannabinoids in appetite regulation has been extensively studied, but the association of cannabis use with weight in the general population is not known. The authors used data from 2 representative epidemiologic studies of US adults aged 18 years or older, the National Epidemiologic Survey on Alcohol and Related Conditions NESARC; 2001-2002 and the National Comorbidity Survey-Replication NCS-R; 2001-2003, to estimate the prevalence of obesity as a function of cannabis use. The adjusted prevalences of obesity in the NESARC and the NCS-R were 22.0% and 25.3%, respectively, among participants reporting no use of cannabis in the past 12 months and 14.3% and 17.2%, respectively, among participants reporting the use of cannabis at least 3 days per week. These differences were not accounted for by tobacco smoking status. Additionally, after adjustment for sex and age, the use of cannabis was associated with body mass index differences in both samples. The authors conclude that the prevalence of obesity is lower in cannabis users than in nonusers.

via Obesity and cannabis use: results from 2 repr... [Am J Epidemiol. 2011] - PubMed - NCBI.